These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

618 related items for PubMed ID: 12593629

  • 1. Reduced brain infarct volume and improved neurological outcome by inhibition of the NR2B subunit of NMDA receptors by using CP101,606-27 alone and in combination with rt-PA in a thromboembolic stroke model in rats.
    Yang Y, Li Q, Yang T, Hussain M, Shuaib A.
    J Neurosurg; 2003 Feb; 98(2):397-403. PubMed ID: 12593629
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Usefulness of postischemic thrombolysis with or without neuroprotection in a focal embolic model of cerebral ischemia.
    Yang Y, Li Q, Miyashita H, Howlett W, Siddiqui M, Shuaib A.
    J Neurosurg; 2000 May; 92(5):841-7. PubMed ID: 10794299
    [Abstract] [Full Text] [Related]

  • 5. Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke.
    Romanos E, Planas AM, Amaro S, Chamorro A.
    J Cereb Blood Flow Metab; 2007 Jan; 27(1):14-20. PubMed ID: 16596120
    [Abstract] [Full Text] [Related]

  • 6. Multitargeted effects of statin-enhanced thrombolytic therapy for stroke with recombinant human tissue-type plasminogen activator in the rat.
    Zhang L, Zhang ZG, Ding GL, Jiang Q, Liu X, Meng H, Hozeska A, Zhang C, Li L, Morris D, Zhang RL, Lu M, Chopp M.
    Circulation; 2005 Nov 29; 112(22):3486-94. PubMed ID: 16316970
    [Abstract] [Full Text] [Related]

  • 7. Experimental modeling of recombinant tissue plasminogen activator effects after ischemic stroke.
    El Amki M, Lerouet D, Coqueran B, Curis E, Orset C, Vivien D, Plotkine M, Marchand-Leroux C, Margaill I.
    Exp Neurol; 2012 Dec 29; 238(2):138-44. PubMed ID: 22921458
    [Abstract] [Full Text] [Related]

  • 8. Serum S100B indicates successful combination treatment with recombinant tissue plasminogen activator and MK-801 in a rat model of embolic stroke.
    Tanaka Y, Marumo T, Omura T, Yoshida S.
    Brain Res; 2007 Jun 18; 1154():194-9. PubMed ID: 17475227
    [Abstract] [Full Text] [Related]

  • 9. Combination therapy of rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, and NMDA receptor antagonist (MK-801) on experimental embolic stroke in rats.
    Allahtavakoli M, Shabanzadeh A, Roohbakhsh A, Pourshanazari A.
    Basic Clin Pharmacol Toxicol; 2007 Nov 18; 101(5):309-14. PubMed ID: 17910613
    [Abstract] [Full Text] [Related]

  • 10. Treatment of embolic stroke in rats with bortezomib and recombinant human tissue plasminogen activator.
    Zhang L, Zhang ZG, Liu X, Hozeska A, Stagliano N, Riordan W, Lu M, Chopp M.
    Thromb Haemost; 2006 Jan 18; 95(1):166-73. PubMed ID: 16543976
    [Abstract] [Full Text] [Related]

  • 11. Improved perfusion with rt-PA and hirulog in a rabbit model of embolic stroke.
    Yenari MA, de Crespigny A, Palmer JT, Roberts S, Schrier SL, Albers GW, Moseley ME, Steinberg GK.
    J Cereb Blood Flow Metab; 1997 Apr 18; 17(4):401-11. PubMed ID: 9143222
    [Abstract] [Full Text] [Related]

  • 12. Adjuvant therapies using normobaric oxygen with hypothermia or ethanol for reducing hyperglycolysis in thromboembolic cerebral ischemia.
    Cai L, Stevenson J, Peng C, Xin R, Rastogi R, Liu K, Geng X, Gao Z, Ji X, Rafols JA, Ji Z, Ding Y.
    Neuroscience; 2016 Mar 24; 318():45-57. PubMed ID: 26794589
    [Abstract] [Full Text] [Related]

  • 13. Recombinant human tissue plasminogen activator protects the basal lamina in experimental focal cerebral ischemia.
    Burggraf D, Martens HK, Jäger G, Hamann GF.
    Thromb Haemost; 2003 Jun 24; 89(6):1072-80. PubMed ID: 12783121
    [Abstract] [Full Text] [Related]

  • 14. Neuroprotection afforded by a combination of eliprodil and a thrombolytic agent, rt-PA, in a rat thromboembolic stroke model.
    Lekieffre D, Benavides J, Scatton B, Nowicki JP.
    Brain Res; 1997 Nov 21; 776(1-2):88-95. PubMed ID: 9439799
    [Abstract] [Full Text] [Related]

  • 15. Combination Therapy Stroke Trial: recombinant tissue-type plasminogen activator with/without lubeluzole.
    Grotta J, Combination Therapy Stroke Trial Investigators.
    Cerebrovasc Dis; 2001 Nov 21; 12(3):258-63. PubMed ID: 11641593
    [Abstract] [Full Text] [Related]

  • 16. Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat.
    Jiang Q, Zhang RL, Zhang ZG, Ewing JR, Divine GW, Chopp M.
    J Cereb Blood Flow Metab; 1998 Jul 21; 18(7):758-67. PubMed ID: 9663506
    [Abstract] [Full Text] [Related]

  • 17. FK-506 extended the therapeutic time window for thrombolysis without increasing the risk of hemorrhagic transformation in an embolic rat stroke model.
    Okubo S, Igarashi H, Kanamatsu T, Hasegawa D, Orima H, Katayama Y.
    Brain Res; 2007 Apr 27; 1143():221-7. PubMed ID: 17316578
    [Abstract] [Full Text] [Related]

  • 18. Combination therapy of moderate hypothermia and thrombolysis in experimental thromboembolic stroke--an MRI study.
    Kollmar R, Henninger N, Bardutzky J, Schellinger PD, Schäbitz WR, Schwab S.
    Exp Neurol; 2004 Nov 27; 190(1):204-12. PubMed ID: 15473993
    [Abstract] [Full Text] [Related]

  • 19. Effect of recombinant plasminogen activator timing on thrombolysis in a novel rat embolic stroke model.
    Ma Y, Li L, Niu Z, Song J, Lin Y, Zhang H, Du G.
    Pharmacol Res; 2016 May 27; 107():291-299. PubMed ID: 27038532
    [Abstract] [Full Text] [Related]

  • 20. Delayed rt-PA treatment in a rat embolic stroke model: diagnosis and prognosis of ischemic injury and hemorrhagic transformation with magnetic resonance imaging.
    Dijkhuizen RM, Asahi M, Wu O, Rosen BR, Lo EH.
    J Cereb Blood Flow Metab; 2001 Aug 27; 21(8):964-71. PubMed ID: 11487732
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.